Dr Yang Meng MSc (Warwick), PhD (Warwick)
HEDS, ScHARR
The University of Sheffield
Regent Court
30 Regent Street
Sheffield
S1 4DA
UK
Office:
Tel: (+44) (0)114 222 0673
Fax: (+44) (0)114 272 4095
E-mail: y.meng@sheffield.ac.uk
Biography
I joined the HEDS section of ScHARR in March 2009 after graduating with a MSc in Management Science and Operational Research from the University of Warwick in 2005 and a PhD in Operational Research (Simulation Modelling) from the University of Warwick in 2009.
I am currently working as a healthcare modeller in the Health Economics and Decision Science (HEDS) section of ScHARR.
Research interests
My research interests are:
- • Alcohol policy appraisal and evaluation using decision modelling
• Healthcare modelling
• Agent-based simulation and discrete-event simulation
• Disease transmission models
Teaching interests
My teaching interests lie in Advanced Simulation Methods, Operational Research Techniques in Health Resource Allocation. I am interested in supervising Research Students in topics/areas such as public health policy appraisal and evaluation using decision modelling and general healthcare cost-effectiveness modelling.
Professional activities
I am a member of the Sheffield Alcohol Research Group.
I am the co-investigator of the ‘enhancements to angioplasty for peripheral arterial occlusive disease (PAOD): systematic review, cost-effectiveness assessment and expected value of information analysis’, funded by NICE HTA program.
I recently worked on the following projects:
• A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease (funded by the NIHR HTA Programme)
• Economical evaluation of the use of positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in breast cancer (funded by NHS R&D HTA program)
• Modelling to assess the effectiveness and cost-effectiveness of public health related strategies and interventions to reduce alcohol attributable harm in England (funded by NICE)
• The application of agent-based simulation to the modelling and management of hospital-acquired infections (PhD topic)
Current projects
I am currently working on the following project:
• Interdisciplinary alcohol policy effectiveness research program (IARP) (funded by the MRC and ESRC)
• Modelling the impact of minimum pricing and promotion polices for alcohol in Scotland (funded by Scottish government)
Key publications (NB up to 6)
• Meng Y, Squires H, Stevens J, Simpson E, Harnan S, et al. Cost-effectiveness of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease in the UK. British Medical Journal (submitted)
• Squires H, Simpson E, Meng Y, Harnan S, Stevens J, et al. A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease. Health Technology Assessment 2011; 15(40):1-210 .
• Meng Y, Ward S, Cooper K, Harnan S, Wyld L. Cost-effectiveness of MRI and PET for the evaluation of axillary lymph node metastases in early stage breast cancer. European Journal of Surgical Oncology 2011; 37(1):40-46
• Cooper K, Meng Y, Harnan S, Ward S, Fitzgerald P,
et al. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in breast cancer: systematic review and economic evaluation. Health Technology Assessment 2011; 15(4):1-134.
• Meng Y, Purshouse R, Brennan A, Meier P.
Model-based appraisal of alcohol minimum pricing and off-licensed trade discount bans in Scotland using the Sheffield Alcohol Policy Model (v.2): An update based on newly available data. The Scottish Government 2010 (http://www.scotland.gov.uk/Publications/2010/04/ 20091852/0).
• Meng Y, Davies R, Hardy K, Hawkey P.
The application of agent-based simulation to the modelling of MRSA transmission in hospital. Journal of Simulation 2010;4:60-7.
Links: